RS
Distinguished in Multiple Epiphyseal Dysplasia
Check Ravi Savarirayan's experience treating your condition:
About Ravi Savarirayan

Ravi Savarirayan practices in Parkville, Australia. Savarirayan is rated as a Distinguished expert by MediFind in the treatment of Multiple Epiphyseal Dysplasia. He is also highly rated in 35 other conditions, according to our data. His top areas of expertise are Achondroplasia, Acanthosis Nigricans, Type A Insulin Resistance Syndrome, and Short Stature Growth Disorders.

His clinical research consists of co-authoring 122 peer reviewed articles and participating in 3 clinical trials in the past 15 years. In particular, he has co-authored 13 articles and participated in 3 clinical trials in the study of Multiple Epiphyseal Dysplasia.

Locations
Murdoch Children's Hospital, Parkville, VIC 3052, AU
Other Locations
Murdoch Children's Research Institute, Parkville, AU
Background & Education
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

Phase 2, Open-Label, Dose-Escalation and Dose-Expansion Study of Infigratinib, an FGFR 1-3-Selective Tyrosine Kinase Inhibitor, in Children With Achondroplasia: PROPEL 2
Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyrosine Kinase Inhibitor, in Children With Achondroplasia: PROPEL OLE
122 Total Publications

Growth parameters in children with achondroplasia: A 7-year, prospective, multinational, observational study.


Save this expert for later
Sign Up
Looking for the best expert for you?
Start Here
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more